Congenital Abnormalities: Clinical Trials

67 trials for Congenital Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 9 recruiting, 9 unknown, 7 terminated. 67 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 167Completed 29, Recruiting 9, Unknown 9, Terminated 7, Not yet recruiting 5, Withdrawn 4, Active not recruiting 2, Enrolling by invitation 2

Follow Congenital Abnormalities: new trials by email Literature Review of Congenital Abnormalities trials Research Report on Congenital Abnormalities

Trials (filtered) newest first · largest first

All 67 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease
GBP-213 - Autosomal Dominant Polycystic Kidney
Early Phase 1Not yet recruitingRenJi Hospital242026-11-012026-10-23
A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.
sirolimus topical gel 0.2% - Epidermal Nevi
Early Phase 1Not yet recruitingNorthwestern University142026-10-012026-09-10
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
Gentamicin, Lactobacillus Rhamnosus GG - Spinal Cord Injury, Neurogenic Bladder (NB)
Early Phase 1Not yet recruitingMedstar Health Research Institute482026-08-012026-08-21
Role of (Saline- Glycerin) Rectal Enema in Treatment of Fecal Incontinence in Children
Rectal enema using saline and glycerin mixture once daily - Anorectal Malformation
Early Phase 1Not yet recruitingSohag University302026-02-152026-02-06
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Indocyanine Green - Biliary Atresia, Kasai
Early Phase 1RecruitingUniversity of Alabama at Birmingham152026-01-232026-02-18
Thera-Clean® Microbubbles System in Patients With Skin Diseases
TheraClean - Epidermolysis Bullosa, Ichthyosis
Early Phase 1Enrolling by invitationNorthwestern University202026-01-132026-02-03
Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study
Daratumumab - Cavernous Malformation, Cerebral
Early Phase 1Not yet recruitingBeijing Tiantan Hospital102025-07-012025-06-18
Calcium Folinate Treatment of Spastic Paraplegia 56
calcium folinate - Hereditary Spastic Paraplegia
Early Phase 1RecruitingShanghai 6th People's Hospital102024-07-012024-06-27
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Thiamine - Congenital Heart Disease, Thiamine Deficiency
Early Phase 1CompletedUniversitas Sumatera Utara862024-05-012026-03-24
Hyaluronidase Via LADD Scleroderma-induced Microstomia
Hyaluronidase, CO2 laser - Microstomia, Scleroderma
Early Phase 1CompletedUniversity of Nebraska32024-03-012026-04-15
Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma
AGV plate, bevacizumab injection - Pediatric Glaucoma
Early Phase 1CompletedBenha University502024-02-092025-05-21
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
The use of a combination of microelements and vitamins against the background of physiotherapy - Respiratory Diseases, Congenital Heart Defects
Early Phase 1Enrolling by invitationTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan6002023-11-082026-09-03
Effect of Antibiotics on Urinary Microbiome
Bactrim DS 800Mg-160Mg Tablet, Placebo oral tablet - Microtia, UTI
Early Phase 1WithdrawnJohns Hopkins University2023-10-012021-11-03
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Dupilumab - Skin Diseases
Early Phase 1RecruitingNorthwestern University302023-06-122026-05-01
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study
LUX-Dx™ - Univentricular Heart
Early Phase 1CompletedBoston Children's Hospital102023-03-152026-05-19
Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution
APR-TD011 - Epidermolysis Bullosa
Early Phase 1CompletedNorthwestern University152023-02-062025-04-27
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Saxenda - Panhypopituitarism, Craniopharyngioma
Early Phase 1UnknownSeoul National University Hospital502022-11-282024-01-23
Effect of Parenteral Alpha-Tocopherol in the Definitive Surgery of Tetralogy of Fallot
alpha-Tocopherol, Sterile Water for Injection - Tetralogy of Fallot (TOF), Alpha-tocopherol
Early Phase 1CompletedDr Cipto Mangunkusumo General Hospital602022-05-012025-09-26
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
Spironolactone, Placebo - Hyperandrogenism, Polycystic Ovary Syndrome
Early Phase 1RecruitingUniversity of Virginia322021-11-122025-08-05
A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis
CD19/BCMA CAR T-cells - POEMS Syndrome, Amyloidosis
Early Phase 1UnknownZhejiang University752021-10-082022-03-03

Showing 20 of 67. Sign in to see all of them.

Narrower conditions

Heart Defects, Congenital (6)  ·  Epidermolysis Bullosa (4)  ·  Hyperandrogenism (4)  ·  Polycystic Ovary Syndrome (4)  ·  Epidermolysis Bullosa Dystrophica (3)  ·  Ichthyosis (3)  ·  POEMS Syndrome (3)  ·  Biliary Atresia (2)  ·  Brain Neoplasms (2)  ·  Congenital Microtia (2)  ·  Hemangioma, Cavernous, Central Nervous System (2)  ·  Hydrophthalmos (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Microstomia (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (67)  ·  Cardiovascular Diseases (21)  ·  Nervous System Diseases (21)  ·  Neoplasms (17)  ·  Cardiovascular Abnormalities (16)  ·  Genetic Diseases, Inborn (16)  ·  Female Urogenital Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (14)  ·  Male Urogenital Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Urogenital Diseases (14)  ·  Abnormalities, Multiple (13)  ·  Skin and Connective Tissue Diseases (12)  ·  Skin Diseases (11)

Interventions

Bevacizumab (3)  ·  Spironolactone (3)  ·  Magnetic Resonance Spectroscopy (2)  ·  Progesterone (2)  ·  fludarabine (2)  ·  Acamprosate (1)  ·  Albuterol (1)  ·  Alemtuzumab (1)  ·  Baclofen (1)  ·  Blood Specimen Collection (1)  ·  Busulfan (1)  ·  Calcium Dobesilate (1)  ·  Chondroitinases and Chondroitin Lyases (1)  ·  Coconut Oil (1)  ·  Continuous Positive Airway Pressure (1)

Sponsors

Northwestern University (7)  ·  University of Virginia (4)  ·  Mayo Clinic (3)  ·  Brigham and Women's Hospital (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  Tongji Hospital (2)  ·  Alta Bates Summit Medical Center (1)  ·  Beijing Tiantan Hospital (1)  ·  Benha University (1)  ·  Biogen (1)  ·  Boston Children's Hospital (1)  ·  CHU de Quebec-Universite Laval (1)  ·  Cairo University (1)  ·  Carelon Research (1)  ·  Children's Hospital of Philadelphia (1)

Countries

United States (43)  ·  China (6)  ·  Egypt (3)  ·  Indonesia (2)  ·  Canada (1)  ·  Iran (1)  ·  Israel (1)  ·  Norway (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Uzbekistan (1)  ·  Vietnam (1)

Top investigators

Amy Paller, MD (3)  ·  Christine Burt Solorzano, MD (2)  ·  Alan L. Ho, MD, PhD (1)  ·  Alicia Y Christy, M.D. (1)  ·  Amanda Garver, DO (1)  ·  Amy Paller (1)  ·  Andrew J Cohen, MD (1)  ·  Andrew Lovering, PhD (1)  ·  Angela Christiano, PhD (1)  ·  Angela Dispenzieri, M.D. (1)  ·  Blaine Hart, MD (1)  ·  Bohdan Pomahac, MD (1)  ·  Casandra Fink (1)  ·  Chia-Che Wu, MD (1)  ·  Christine Burt Solorzano, M.D. (1)

Results publications

PMID 17635375, PMID 21946867, PMID 23481118, PMID 29300925, PMID 30256977, PMID 35391541, PMID 36167501, PMID 37658205, PMID 40425008, PMID 41101309

NIH funding

P50HD028934 (1), R01HD102060 (1), R01HL117836 (1), U54HD082008 (1), U54NS065705 (1), UL1TR002366 (1)